Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Shoji Yamazaki"'
Autor:
Yuji Kashiwakura, Kazuhiro Endo, Atsushi Ugajin, Tomohiro Kikuchi, Shuji Hishikawa, Hitoyasu Nakamura, Yuko Katakai, Nemekhbayar Baatartsogt, Takafumi Hiramoto, Morisada Hayakawa, Nobuhiko Kamoshita, Shoji Yamazaki, Akihiro Kume, Harushi Mori, Naohiro Sata, Yoichi Sakata, Shin-ichi Muramatsu, Tsukasa Ohmori
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 30, Iss , Pp 502-514 (2023)
Gene therapy using adeno-associated virus (AAV)-based vectors has become a realistic therapeutic option for hemophilia. We examined the potential of a novel engineered liver-tropic AAV3B-based vector, AAV.GT5, for hemophilia B gene therapy. In vitro
Externí odkaz:
https://doaj.org/article/e60d3f3fd02c459c99665b37f69364fb
Autor:
Yuji Kashiwakura, Nemekhbayar Baatartsogt, Shoji Yamazaki, Azusa Nagao, Kagehiro Amano, Nobuaki Suzuki, Tadashi Matsushita, Akihiro Sawada, Satoshi Higasa, Naoya Yamasaki, Teruhisa Fujii, Taemi Ogura, Hideyuki Takedani, Masashi Taki, Takeshi Matsumoto, Jun Yamanouchi, Michio Sakai, Masako Nishikawa, Yutaka Yatomi, Koji Yada, Keiji Nogami, Ryota Watano, Takafumi Hiramoto, Morisada Hayakawa, Nobuhiko Kamoshita, Akihiro Kume, Hiroaki Mizukami, Shizukiyo Ishikawa, Yoichi Sakata, Tsukasa Ohmori
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 27, Iss , Pp 404-414 (2022)
Adeno-associated virus (AAV) vectors are promising modalities of gene therapy to address unmet medical needs. However, anti-AAV neutralizing antibodies (NAbs) hamper the vector-mediated therapeutic effect. Therefore, NAb prevalence in the target popu
Externí odkaz:
https://doaj.org/article/b43dde9c693b47fc933baa57f7dd8461
Publikováno v:
AIJ Journal of Technology and Design. 28:1432-1437
Publikováno v:
Proceedings of the City Planning Institute of Japan, Chubu Branch. 32:61-64
Autor:
Kazuomi Kario, Kenta Okada, Mitsutoshi Kato, Masafumi Nishizawa, Tetsuro Yoshida, Tsuguyoshi Asano, Kazuaki Uchiyama, Yawara Niijima, Tomohiro Katsuya, Hidenori Urata, Jun-ichi Osuga, Takeshi Fujiwara, Shoji Yamazaki, Naoko Tomitani, Hiroshi Kanegae, Satoshi Hoshide, Mitsuyoshi Yamamoto, Kazuo Eguchi, Atsushi Mizuno, Shigeru Nakano, Yuta Kemi, Chie Iwashita, Kyouichi Wada, Azusa Kaneko, Nicola Ryan
Publikováno v:
Circulation. 139:2089-2097
Background: The risk of cardiovascular disease and mortality in salt-sensitive patients with diabetes mellitus and uncontrolled nocturnal hypertension is high. The SACRA (Sodium-Glucose Cotransporter 2 [SGLT2] Inhibitor and Angiotensin Receptor Block
Autor:
Kazuro Yagi, Kazuomi Kario, Koichiro Yamasaki, Naoko Tomitani, Masatoshi Tsukamoto, Yukie Okawara, Shoji Yamazaki, Hiroshi Kanegae
Publikováno v:
The Journal of Clinical Hypertension. 21:896-903
Orexins are neuropeptides that play a role in maintaining wakefulness and contribute to central regulation of cardiovascular function. This first multicenter, randomized, double-blind study investigated the effects of suvorexant, a reversible dual or
Autor:
Shoji Yamazaki
Publikováno v:
Indoor Environment. 10:17-22
Publikováno v:
Bioscience and Microflora. 22:85-91
The effects of Bifidobacterium longum BB536 (BB536) on Escherichia coli O157:H7 IPH9 (IPH9) were first examined using germ-free mice mono-associated with BB536 (BB536-MA). Thirty-two days after oral challenge with a lethal dose of IPH9, all the non-a
Autor:
Akihiko Tokue, Hitoshi Endo, Masaki Baba, Shoji Yamazaki, Toshiro Hamamoto, Toru Okuyama, Yoshiko Joichi, Sanae Kaneko, Tatuo Morita, Hoyoku Nishino, Yoshihito Okada
Publikováno v:
Cancer Letters. 183:23-30
Isoliquiritigenin is a chalcone isolated from licorice and shallots. The ability of isoliquiritigenin to suppress metastasis was examined in a pulmonary metastasis model of mouse renal cell carcinoma. Isoliquiritigenin significantly reduced pulmonary
Autor:
Shoji Yamazaki, Fujio Senba, Yasuko Tomokiyo, Shinichiro Komiyama, Michikazu Ohbayashi, Keiko Nakano, Akio Fujimura, Kazuhiro Harada, Masafumi Okada, Kumio Ikeba
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 33:127-130
We prospectively surveyed how frequently drugs were prescribed that could cause harmful drug interactions, and evaluated the effect of providing the physicians with information concerning drug interactions on the frequency of such prescriptions.At se